Chinas Tungsten Exports to Japan Drop by Half as Export Controls Tighten LongTerm Potential of AI Stocks A Decade Outlook Vestas Wind Systems Shares Decline After Margin Guidance Update Signos Raises 20M in Funding Partners with Dexcom to Expand AIPowered Weight Loss Platform Ashok Leyland Reports Stabilizing Ras Al Khaimah Operations Saudi Manufacturing Plans on Schedule Microsoft Names Jenny LayFlurrie to Lead Trusted Technology Amid AI Speed vs Responsibility Debate CDZIP Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 36 YTRA Q1 2026 Earnings Narrower Loss than Expected Shares Rally 6 KWR Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Edges Lower Brighthouse Financial Q1 2026 Earnings Insurance Giant Misses EPS Estimates Amid Market Volatility First Seacoast Bancorp FSEA Q3 2024 Earnings Modest Profit Despite Quiet Quarter TOWN Q1 2026 Earnings EPS Misses Estimates by Nearly 5 Stock Edges Lower Nova Minerals NVA Declines Over 5 as Support Levels Near BULLW Warrants Slide 954 as Webulls Equitylinked Securities Test Key Support Masco Corporation MAS Advances Amid Sector Strength Key Resistance in Focus Netcapital Inc NCPL Holds Steady Near Support After Minimal Decline Ralph Lauren RL Edges Higher Key Levels to Watch After Modest Gain OOMA Q1 2026 Earnings EPS Surpasses Estimates with 786 Beat ONB Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Edges Higher AXR Q1 2026 Earnings Slight EPS Beat Marks a Quiet Quarter JHG Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds HESM Q1 2026 Earnings EPS Beat of 325 Drives Modest Stock Gain CBRE Q1 2026 Earnings Stellar EPS Beat Underscores Resilient Business Model OpenAI Poised to Lead AI IPO Race with Confidential Filing Report PROCEPT BioRobotics Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress LB Pharmaceuticals LBRX Holds Near Resistance as Modest Gain Signals Consolidation SSP Q1 2026 Earnings EPS Surpasses Expectations by 619 as Cost Controls Drive Profitability ATOS Q1 2026 Earnings Narrowing Loss Exceeds Expectations Amid Clinical Progress Penumbra Q1 2026 Earnings EPS Misses Estimates by 245 Amidst Operational Headwinds VELO Q1 2026 Earnings Strong EPS Beat Shocks Market Revenue Remains Undisclosed CNTB Q1 2026 Earnings WiderthanExpected Loss as Development Pipeline Advances Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher